Expanding Psychopharmacologic Treatment Options for the Depressed Medical Patient
- 30 April 1995
- journal article
- review article
- Published by Elsevier in Psychosomatics
- Vol. 36 (2) , S19-S26
- https://doi.org/10.1016/s0033-3182(95)71700-5
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- The Effects of Nefazodone on Sleep Architecture in DepressionNeuropsychopharmacology, 1994
- Dyskinesia Associated with FluvoxamineJournal of Clinical Psychopharmacology, 1993
- Abnormal Platelet Aggregation Associated with Fluoxetine TherapyAnnals of Pharmacotherapy, 1992
- Fluoxetine impairs clearance of alprazolam but not of clonazepamClinical Pharmacology & Therapeutics, 1992
- The effect of selective serotonin re‐uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes.British Journal of Clinical Pharmacology, 1992
- Cardiovascular effects of bupropion in depressed patients with heart diseaseAmerican Journal of Psychiatry, 1991
- Fluoxetine, Fluvoxamine and Extrapyramidal Tract DisordersInternational Clinical Psychopharmacology, 1991
- Evaluation of the potential for interactions of paroxetine with diazepam, cimetidine, warfarin, and digoxinActa Psychiatrica Scandinavica, 1989
- Age, sex, and nitrazepam kinetics: Relation to antipyrine dispositionClinical Pharmacology & Therapeutics, 1985
- Effect of age and liver cirrhosis on the pharmacokinetics of nitrazepam.British Journal of Clinical Pharmacology, 1983